Lupus

1. Lupus4 Jul 2026

   Association of systemic lupus erythematosus with 90-day readmission following heart failure hospitalization: A national readmission database (NRD) analysis, 2016–2017

   Cohort studyLupus & APS

2. Lupus2 Jul 2026

   An evidence-based specialist nursing protocol for children with hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) and its application research

   Cohort studyPediatric

3. Lupus2 Jul 2026

   T-bet expression in B cell subsets: Association with T peripheral helper cells and clinical activity in systemic lupus erythematosus

   Cross-sectional studyLupus & APS

4. Lupus2 Jul 2026

   Autonomic dysfunction in systemic lupus erythematosus and systemic sclerosis

   Cross-sectional studyLupus & APS

5. Lupus2 Jul 2026

   Association of GPX4 rs713041 and rs4807542 polymorphisms and serum GPX4 levels in Chinese patients with systemic lupus erythematosus

   Case-control studyLupus & APS

6. Lupus28 Jun 2026

   Association of serum and urinary galectin-3 with renal fibrosis in patients with lupus nephritis: A cross-sectional controlled study

   Cross-sectional studyLupus & APS

7. Lupus25 Jun 2026

   Continuation of belimumab in patients with systemic lupus erythematosus in a real-world setting: A single-center retrospective cohort study

   Cohort studyLupus & APS

8. Lupus23 Jun 2026

   Clinical and histopathological predictors of systemic lupus erythematosus in a South American cohort of patients with full-house glomerulonephritis

   Cohort studyLupus & APS

9. Lupus23 Jun 2026

   Longitudinal observation of thrombotic events in patients with obstetric antiphospholipid syndrome

   Cohort studyLupus & APS

10. Lupus23 Jun 2026

    Serum RIPK3/MLKL as exploratory biomarker candidates for systemic lupus erythematosus

    Case-control studyLupus & APS

11. Lupus17 Jun 2026

    The lived experiences of woman navigating university with lupus and their primary support persons

    Research articleLupus & APS

12. Lupus16 Jun 2026

    Treatment strategies and clinical outcomes in shrinking lung syndrome in systemic lupus erythematosus: An updated systematic review

    Meta-analysisLupus & APS

13. Lupus15 Jun 2026

    Skin involvement in the catastrophic antiphospholipid syndrome: A review from CAPS registry

    Cross-sectional studyLupus & APS

14. Lupus11 Jun 2026

    Outcomes of systemic lupus erythematosus hospitalisations in Qatar: Insights from a multinational tertiary centre experience

    Cohort studyLupus & APS

15. Lupus10 Jun 2026

    Comparative performance of lupus disease-activity indices during pregnancy to predict adverse obstetric outcomes: A colombian SLE cohort

    Cohort studyLupus & APS

16. Lupus5 Jun 2026

    Kidney outcomes in pure membranous versus proliferative lupus nephritis: A 14-year Latin American cohort study

    Cohort studyLupus & APS

17. Lupus3 Jun 2026

    Unveiling the role of TLR9 promoter variants in susceptibility and clinical features of systemic lupus erythematosus

    Case-control studyLupus & APS

18. Lupus3 Jun 2026

    A quality improvement project to incorporate the mycophenolate Risk Evaluation and Mitigation Strategies in an academic lupus clinic

    Research articleLupus & APS

19. Lupus1 Jun 2026

    Comparative study of adverse drug reactions associated with anifrolumab and belimumab for the treatment of systemic lupus erythematosus

    Cohort studyLupus & APS

20. Lupus6 May 2026

    Factors associated with changes in self-efficacy in patients with systemic lupus erythematosus. Data from the almenara lupus cohort

    Cohort studyLupus & APS

21. Lupus6 May 2026

    Morbidity and mortality in primary versus secondary antiphospholipid syndrome: A single-center study using the 2023 ACR/EULAR criteria

    Cohort studyLupus & APS

22. Lupus6 May 2026

    Lower-dose glucocorticoid therapy achieves comparable outcomes in Japanese patients with lupus nephritis

    Cohort studyLupus & APS

23. Lupus30 Apr 2026

    Geographic distribution of mortality from systemic lupus erythematosus

    Research articleLupus & APS

24. Lupus28 Apr 2026

    Treatment patterns and outcomes of first lupus nephritis episode over 25 years in two Latin American cohorts

    Cohort studyLupus & APS

25. Lupus24 Apr 2026

    Nationwide analysis of childhood-onset systemic lupus erythematosus mortality in Mexico, 2000–2023

    Cross-sectional studyPediatric

26. Lupus20 Apr 2026

    Primary headaches in juvenile-onset systemic lupus erythematosus: A preliminary case control study using ICHD-3 criteria

    Cross-sectional studyPediatric

27. Lupus16 Apr 2026

    Association between interstitial fibrosis/tubular atrophy (IFTA) on kidney biopsies and anti Ro60 antibody positivity in patients with lupus nephritis (LN)

    Cohort studyLupus & APS

28. Lupus13 Apr 2026

    Clinical outcomes of anifrolumab after belimumab failure in systemic lupus erythematosus: A single-center case series

    Cohort studyLupus & APS

29. Lupus13 Apr 2026

    Diagnostic performance of anti-DFS70 antibodies in excluding systemic lupus erythematosus diagnosis: An updated systematic review and meta-analysis

    Meta-analysisLupus & APS

30. Lupus9 Apr 2026

    Adoption of multimodal echocardiography in evaluating left ventricular systolic synchrony in patients with systemic lupus erythematosus

    Diagnostic or prognostic studyLupus & APS

31. Lupus8 Apr 2026

    Prognostic risk score for end-stage kidney disease in Latin American lupus nephritis: Integrating clinical and histological data

    Cohort studyLupus & APS

32. Lupus8 Apr 2026

    Long-term outcomes of patients with moderate-severe pediatric systemic lupus erythematosus treated with combination rituximab and cyclophosphamide therapy: A single center cohort experience and review of literature

    Cohort studyPediatric

33. Lupus4 Apr 2026

    Development and evaluation of frailty index for patients with systemic lupus erythematosus in China

    Diagnostic or prognostic studyLupus & APS

34. Lupus1 Apr 2026

    Real-world use of anifrolumab in systemic lupus erythematosus: A retrospective study from a Danish tertiary center (2022–2025)

    Cohort studyLupus & APS

35. Lupus28 Mar 2026

    Relationship between sarcopenia and lifestyle in patients with systemic lupus erythematosus: A one-institution cross-sectional analysis

    Cross-sectional studyLupus & APS

36. Lupus27 Mar 2026

    A conceptual model of the patient experience of cutaneous lupus erythematosus

    Research articleLupus & APS

37. Lupus26 Mar 2026

    Patient perspectives on SLE, refractory APS, and biologic drug use during pregnancy

    Cross-sectional studyLupus & APS

38. Lupus24 Mar 2026

    Frequency and clinical associations of Epstein-Barr virus molecular detection in systemic lupus erythematosus: A follow-up study

    Cohort studyLupus & APS

39. Lupus23 Mar 2026

    LUNELORD: A descriptive, prospective study on the demographics, disease characteristics and health-related quality of life of patients with LUpus NEphritis and long-term ORgan damage in rheumatology clinics in the Arabian Gulf

    Cohort studyLupus & APS

40. Lupus20 Mar 2026

    Beyond glomeruli in lupus nephritis: Impact of tubulointerstitial inflammation and interstitial fibrosis/tubular atrophy on renal function decline – A systematic review and meta-analysis

    Meta-analysisLupus & APS

All 555 Briefs in ExploreShowing Briefs 41–80 of 555, newest first